Abstract | OBJECTIVE: DATA SOURCES AND STUDY SELECTION: DATA EXTRACTION: A random-effects model was used to calculate the standardized mean difference of change in anxiety rating scale scores with D- cycloserine augmentation compared to placebo, which was the primary outcome measure. Subgroup analysis and meta-regression were used to examine the effects of D- cycloserine dosage and timing (relative to exposure therapy), diagnostic indication, number of therapy sessions, and trial methodological quality on D- cycloserine efficacy. RESULTS: Meta-analysis of 9 trials involving 273 subjects demonstrated a significant benefit from D- cycloserine augmentation (standardized mean difference = 0.46 [95% CI, 0.15 to 0.77], z = 2.89, P = .004). There was no evidence of publication bias, but a moderate, nonsignificant degree of heterogeneity between trials (I2 = 36%, Q = 12.6, df = 8, P = .12) was found. Secondary analyses yielded no significant findings. CONCLUSIONS: D- Cycloserine appears to be an effective augmentation agent that enhances the effects of behavioral therapy in the treatment of anxiety disorders. In contrast to a previous meta-analysis that examined D- cycloserine's effects in both animals and humans, we found no evidence of an effect of dose number, dose timing, or dosage of D- cycloserine on reported efficacy in the ranges studied.
|
Authors | Allyson Bontempo, Kaitlyn E Panza, Michael H Bloch |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 73
Issue 4
Pg. 533-7
(Apr 2012)
ISSN: 1555-2101 [Electronic] United States |
PMID | 22579153
(Publication Type: Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © Copyright 2012 Physicians Postgraduate Press, Inc. |
Chemical References |
- Anti-Anxiety Agents
- Cycloserine
|
Topics |
- Anti-Anxiety Agents
(administration & dosage, therapeutic use)
- Anxiety Disorders
(drug therapy, therapy)
- Behavior Therapy
(methods)
- Combined Modality Therapy
- Cycloserine
(administration & dosage, therapeutic use)
- Humans
- Treatment Outcome
|